Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2019

Schedule of cash, cash equivalents, and restricted cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash as reported within the Unaudited Condensed Consolidated Balance Sheets to “Cash, cash equivalents, and restricted cash at end of period” as reported within the Unaudited Condensed Consolidated Statements of Cash Flows:



In thousands	March 31, 2019		December 31, 2018
Cash and cash equivalents	$	5,749	$	38,560
Restricted cash included in other assets	16,558		16,389
Total cash, cash equivalents, and restricted cash shown in the Unaudited Condensed Consolidated Statements of Cash Flows	$	22,307	$	54,949

Schedule of earnings per share, basic and diluted reconciliation

The following table sets forth the reconciliations of net income (loss) and weighted average shares used for purposes of calculating the basic and diluted net income (loss) per common share for the periods indicated:



	Three Months Ended
	March 31,
In thousands	2019			2018
Numerator
Net income (loss) – basic	$	(25,674	)	$	39,578
Effect of potentially dilutive securities
Interest on convertible senior notes	—			501
Net income (loss) – diluted	$	(25,674	)	$	40,079

Denominator
Weighted average common shares outstanding – basic	451,720			392,742
Effect of potentially dilutive securities
Restricted stock and performance-based equity awards	—			5,169
Convertible senior notes	—			53,632
Weighted average common shares outstanding – diluted	451,720			451,543

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The following securities could potentially dilute earnings per share in the future, but were excluded from the computation of diluted net income (loss) per share, as their effect would have been antidilutive:



	Three Months Ended
	March 31,
In thousands	2019	2018
Stock appreciation rights	2,091	2,954
Restricted stock and performance-based equity awards	8,350	431